Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Cartesian Therapeutics Logo
Cartesian Therapeutics Growth Score
93
CB Rank
12596
Heat Score
87
Pioneering Potent, Safer Cell Therapy in and Beyond Oncology
Founded
obfuscation
PublicPost-IPO Debt Gaithersburg, Maryland, United States51-100 www.cartesiantherapeutics.com/
Biotechnology
Oncology
Overview

Cartesian Therapeutics
Total Funding
obfuscation
Growth Score
93
Heat Score
87

Total Funding
obfuscation
obfuscation
Post-IPO Debt raised
obfuscation
Growth Score93
1 pts
in past quarter
Heat Score 87
29 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Cartesian Therapeutics

CB Rank
12596
Pioneering Potent, Safer Cell Therapy in and Beyond Oncology
Founded
obfuscation
PublicPost-IPO Debt Gaithersburg, Maryland, United States51-100 www.cartesiantherapeutics.com/
Biotechnology
Oncology

Funding Rounds

Post-IPO Debt
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

  • Photo of Michael S. Singer
    Michael S. Singer: Chief Scientific Officer, Director, Co-Founder
    Past Role: Topokine Therapeutics, Founder & CSO
  • Photo of Carsten Brunn
    Carsten Brunn: President, Chief Executive Officer
    Past Role: Selecta Biosciences, President and CEO

Details

Legal Name Cartesian Therapeutics, Inc.
Operating Status Active
Stock Symbol  NASDAQ:RNAC
Company Type For Profit
Founders  Michael S. Singer, Murat V. Kalayoglu
About the Company
Cartesian Therapeutics is a fully integrated, clinical-stage biopharmaceutical company developing novel cell and gene immunotherapies to treat cancer and autoimmune diseases.
Predictions & Insights

Growth Insight

See this Growth Insight
Cartesian Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

mRNA Cell Therapy Platform
A platform for developing mRNA-based cell therapies targeting autoimmune diseases.

Research & Development

Cartesian Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Cartesian Therapeutics Logo
Post-IPO Debt - Cartesian Therapeutics
1
obfuscation
K2 HealthVenturesPost-IPO Debt
obfuscation
Post-IPO Debt - Cartesian Therapeutics Logo
Post-IPO Debt - Cartesian Therapeutics
1
obfuscation
K2 HealthVenturesPost-IPO Debt
obfuscation
Post-IPO Debt - Cartesian Therapeutics Logo
Post-IPO Debt - Cartesian Therapeutics
1
obfuscation
K2 HealthVenturesPost-IPO Debt
obfuscation
Post-IPO Debt - Cartesian Therapeutics Logo
Post-IPO Debt - Cartesian Therapeutics
1
obfuscation
K2 HealthVenturesPost-IPO Debt
obfuscation
Post-IPO Debt - Cartesian Therapeutics Logo
Post-IPO Debt - Cartesian Therapeutics
1
obfuscation
K2 HealthVenturesPost-IPO Debt

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Cartesian Therapeutics Logo
Post-IPO Debt - Cartesian Therapeutics
1
obfuscation
K2 HealthVenturesPost-IPO Debt
obfuscation
Post-IPO Debt - Cartesian Therapeutics Logo
Post-IPO Debt - Cartesian Therapeutics
1
obfuscation
K2 HealthVenturesPost-IPO Debt
obfuscation
Post-IPO Debt - Cartesian Therapeutics Logo
Post-IPO Debt - Cartesian Therapeutics
1
obfuscation
K2 HealthVenturesPost-IPO Debt
obfuscation
Post-IPO Debt - Cartesian Therapeutics Logo
Post-IPO Debt - Cartesian Therapeutics
1
obfuscation
K2 HealthVenturesPost-IPO Debt
obfuscation
Post-IPO Debt - Cartesian Therapeutics Logo
Post-IPO Debt - Cartesian Therapeutics
1
obfuscation
K2 HealthVenturesPost-IPO Debt

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
K2 HealthVentures Logo
K2 HealthVentures
Yes
Post-IPO Debt - Cartesian Therapeutics Logo
Post-IPO Debt - Cartesian Therapeutics
—
K2 HealthVentures Logo
K2 HealthVentures
Yes
Post-IPO Debt - Cartesian Therapeutics Logo
Post-IPO Debt - Cartesian Therapeutics
—
K2 HealthVentures Logo
K2 HealthVentures
Yes
Post-IPO Debt - Cartesian Therapeutics Logo
Post-IPO Debt - Cartesian Therapeutics
—
K2 HealthVentures Logo
K2 HealthVentures
Yes
Post-IPO Debt - Cartesian Therapeutics Logo
Post-IPO Debt - Cartesian Therapeutics
—
K2 HealthVentures Logo
K2 HealthVentures
Yes
Post-IPO Debt - Cartesian Therapeutics Logo
Post-IPO Debt - Cartesian Therapeutics
—

Investments

Number of Acquisitions 1

Investment Breakdown

Number of Acquisitions 1
Market Intelligence
People
View Profiles & Contacts
Headcount 51-100 Employee Profiles 5 Board Members and Advisors 4 Contacts 32

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 15, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 15, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 14, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 12, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

2,762
28.17%
 in past month

IT Spend

$79.2KThis year, Cartesian Therapeutics is projected to spend $79.2K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Code Search Logo
Code Search
100
iOS Apps Logo
iOS Apps
94
Patient Data Logo
Patient Data
91

Actively Used Products

5Cartesian Therapeutics uses 5 technology products and services including Google Compute Engine, Google Fonts, and  Wordpress, according to G2 Stack.

Active Website Tech Count

21Cartesian Therapeutics is actively using 21 technologies for its website, according to BuiltWith. These include HSTS, CommonCrawl Top 5m, and  Person Schema.
Sub-Organizations
Frequently Asked Questions

Where is Cartesian Therapeutics's headquarters? Cartesian Therapeutics is located in Gaithersburg, Maryland, United States.Who invested in Cartesian Therapeutics? Cartesian Therapeutics has 7 investors including K2 HealthVentures and  Invus.When was the last funding round for Cartesian Therapeutics? Cartesian Therapeutics closed its last funding round on
obfuscation
from a Post-IPO Debt round.Who are Cartesian Therapeutics's competitors? Alternatives and possible competitors to Cartesian Therapeutics may include Orna Therapeutics, ADARx Pharmaceuticals, and  Entrada Therapeutics.How much funding has Cartesian Therapeutics raised to date? Cartesian Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(6ec160d 1)
|